-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, in a research report titled "Plasma metabolites to profile pathways in noncommunicable disease multimorbidity" published in the international journal Nature Medicine, scientists from Cambridge University and other institutions have identified through research that it can increase individual suffering from one or more This is a key risk factor for the possibility of non-communicable diseases, such as cardiovascular disease, cancer, chronic respiratory disease and diabetes.
In the article, researchers conducted a study of more than 11,000 people and found that people with multiple diseases often have potential biological associations in the body, rather than accidental reasons.
Researcher Claudia Langenberg said that we analyzed the levels of 1014 metabolites in the body of more than 11,000 participants in the European Cancer Prospective Cohort Study (EPIC).
By integrating all existing data to obtain a holistic view, researchers can identify and record the associations between these metabolites and 27 different non-communicable diseases, which often exist in multiple diseases.
The researchers then analyzed the associations between more than 50 characteristics in the participants’ bodies, including waist-to-hip ratio to smoking behavior, etc.
Researcher Maik Pietzner added that we found that two-thirds of small molecules may be related to at least two seemingly unrelated diseases.
Reference materials:
[1] Pietzner, M.
【2】New study finds shared origins for individual chronic diseases in multimorbidity
by UK Research and Innovation